• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/15

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

15 Cards in this Set

  • Front
  • Back
RT dose for Orbital Pseudotumor
20-30 Gy at 2 Gy per fraction or
19.8 Gy at 1.8 Gy per fraction

Mendenhall AJCO 2010.
RT dose for pre-operative deep soft tissue sarcoma
50.4 Gy at 1.8 Gy per fraction in 28 fractions
50.4 Gy at 1.2 Gy per fraction in 42 fractions
RT dose for Stage III Non-small cell lung cancer with concurrent chemotherapy
60 - 74 Gy at 2 Gy per fraction in 30 to 37 fractions
RT Dose for Preoperative Chemoradiation therapy for rectal cancer
45 Gy at 1.8 Gy per fraction in 25 fractions
Boost to 5.4 Gy at 1.8 Gy per fraction in total of 3 fractions
Preoperative radiation therapy Dose for esophageal cancer
45 Gy at 1.8 Gy per fraction in 25 fractions
Boost to 5.4 Gy at 1.8 Gy per fraction in total of 3 fractions
Lymphoma Involved Field Borders for Unilateral Cervical/Supaclavicular Region
Superior: 1-2 cm above the lower tip of the mastoid process and midpoint through the chin
Inferior: 2 cm below clavicle
Lateral: Include medial 2/3 of clavicle
Medial: In SCL nodes are not involved, place border at ipsilateral transvere process unless medial nodes close to vertebral bodies are present in which case cover the entire vertebral body. If SCL nodes are involved place border at contralateral transverse process.

** For stage I, block larynx and vertebral bodies above the larynx- add block at 19.8 Gy.
** Add posterior cervical cord block at 40 Gy
Lymphoma Involved Fields: Paraaortic region
Superior: Top of T11
Inferior: Bottom of L4 and at least 2 cm below pre-chemotherapy volume
Lateral borders: edge of tranverse processes and at least 2 cm from the post-chemo volume

* block kidneys if possible. Include porta hepatis if initially involved.
Oral Cavity: IMRT Neck Coverage
RP: No
Retrosyloid: In hemineck if N+
Level IA: Bilateral
Level IB: Bilateral
Level 2: Bilateral
Level 3: Bilateral
Level 4. Bilateral
Level 5: Usually no, unless
Nasopharynx: IMRT Neck Coverage
RP: Bilateral
Retrostyloid: Bilateral
Level IA: No
Level IB: Bilateral, ant edge of SMG unless positive level II
Level 2: Bilateral
Level 3: Bilateral
Level 4. Bilateral
Level 5: Bilateral
Oropharynx: IMRT Neck Coverage
RP: Bilateral
Retrosyloid: In hemineck if N+
Level IA: No
Level IB: Node positive hemineck, anterior edge of SMG unless level 2 +
Level 2: Bilateral
Level 3: Bilateral
Level 4. Bilateral
Level 5: Only in Node Positive hemineck
Larynx: IMRT Neck Coverage
RP: Only if node + or PPW involved
Retrostyloid space: only in node + hemineck
Level IB: Only in node + hemineck (anterior edge of SMG unless + level 2)
Level 2: Bilateral
Level 3: Bilateral
Level 4: Bilateral
Level 5: Only in neck + hemineck
Hypopharynx: IMRT Neck Coverage
RP: Bilateral
Retrostyloid: Only in Node + hemineck

Level IB: Only in node + hemineck (anterior edge of SMG unless + level 2)
Level 2: Bilateral
Level 3: Bilateral
Level 4: Bilateral
Level 5: Only in node + hemineck
MD Anderson Concomitant Boost Schedule for Head and Neck
PTV Standard Risk: 1.65 x 30 = 49.5 Gy
PTV Intemediate Risk: 1.8 x 30 = 54 Gy
PTV High Risk: 1.8 x 30 = 54 Gy and on last 12 days of treatmen in afternoons,1.5 Gy x 12 totaling 18 Gy and High risk PTV Dose total of 72 Gy

6 weeks of radiotherapy
Airway Obstruction: Acceptable Doses and Fraction Sizes
10 Gy x 1
8.5 Gy x 2, with 1 week separating fxs
4 Gy x 5
2 Gy x 10
2.5 Gy x 15

*Do no exceed spinal cord tolerance using large fractions
*Use caution when treating previously treated areas near major blood vessels
Whole liver RT: Doses and Fractions
3 Gy x 7 doses